P. Wang et al., INHIBITION OF THE BIOLOGIC ACTIVITY OF TUMOR-NECROSIS-FACTOR MAINTAINS VASCULAR ENDOTHELIAL-CELL FUNCTION DURING HYPERDYNAMIC SEPSIS, The journal of trauma, injury, infection, and critical care, 40(5), 1996, pp. 694-701
Background and Objective: Although vascular endothelial cell function
(i,e,, the release of endothelium-derived nitric oxide) decreases and
plasma tumor necrosis factor (TNF) increases during sepsis, it is not
known whether the elevated TNF is responsible for the depression of en
dothelial cell function under such conditions, The aim of this study,
therefore, was to determine if inhibition of TNF biologic activity by
polyethylene glycol dimerized conjugate of the recombinant human form
of the p55 soluble TNF receptor (PEG-(rsTNF-R1)(2)) maintains endothel
ial function during sepsis. Design, Materials, and Methods: Rats were
subjected to sepsis by cecal ligation and puncture (CLP), Immediately
before the onset of sepsis, 600 mu g/rat PEG-(rsTNF-R1)(2) or an equal
volume of saline was infused intravenously, At 10 hours after CLP (i,
e,, hyperdynamic sepsis), the thoracic aorta was isolated, cut into ri
ngs, and placed in organ chambers, Dose responses for an endothelium-d
ependent vasodilator, acetylcholine (ACh), and an endothelium-independ
ent vasodilator, nitroglycerine (NTG), were determined, Endothelial ce
ll structure was examined by transmission electron microscopy. Results
: Endothelium-dependent vascular relaxation was depressed at 10 hours
after the onset of sepsis, Administration of PEG-(rsTNF-R1)(2) before
CLP, however, maintained ACh-induced relaxation, In contrast, no signi
ficant difference in NTG-induced relaxation was seen, irrespective of
administration of PEG-(rsTNF-R1)(2), Furthermore, the deterioration in
endothelial structure during sepsis was prevented by PEG (rsTNF-R1)(2
) pretreatment. Conclusion: Since administration of PEG-(rsTNF-R1)(2)
maintains vascular endothelial cell structure and function, it can be
concluded that TNF plays a pivotal role in producing endothelial dysfu
nction during sepsis, Thus, pharmacologic agents that inhibit TNF biol
ogic activity and/or its production may be useful for protecting endot
helial cells during sepsis.